These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20482513)

  • 1. Medications acting on the dopaminergic system in the treatment of alcoholic patients.
    Swift R
    Curr Pharm Des; 2010; 16(19):2136-40. PubMed ID: 20482513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medications and alcohol craving.
    Swift RM
    Alcohol Res Health; 1999; 23(3):207-13. PubMed ID: 10890816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of alcohol dependence: a review of the clinical data.
    Mann K
    CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurobiological aspects of alcoholism].
    Anokhina IP
    Vestn Akad Med Nauk SSSR; 1988; (3):21-7. PubMed ID: 3388967
    [No Abstract]   [Full Text] [Related]  

  • 5. Medications for Parkinson's disease.
    Whitney CM
    Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine and alcoholism: neurobiological basis of ethanol abuse.
    Tupala E; Tiihonen J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1221-47. PubMed ID: 15588749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone.
    Martinotti G; Di Nicola M; Di Giannantonio M; Janiri L
    J Psychopharmacol; 2009 Mar; 23(2):123-9. PubMed ID: 18515460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic approaches to the management of alcoholism.
    Anton RF
    J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence.
    Ait-Daoud N; Johnson BA; Prihoda TJ; Hargita ID
    Psychopharmacology (Berl); 2001 Feb; 154(1):23-7. PubMed ID: 11292002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the Pharmacological Treatment of Tics with Dopamine-Modulating Agents.
    Mogwitz S; Buse J; Wolff N; Roessner V
    ACS Chem Neurosci; 2018 Apr; 9(4):651-672. PubMed ID: 29498507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial.
    Schacht JP; Voronin KE; Randall PK; Anton RF
    Neuropsychopharmacology; 2018 May; 43(6):1247-1256. PubMed ID: 29362512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine, depression and antidepressants.
    Dailly E; Chenu F; Renard CE; Bourin M
    Fundam Clin Pharmacol; 2004 Dec; 18(6):601-7. PubMed ID: 15548230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development.
    Platt DM; Rowlett JK; Spealman RD
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):265-82. PubMed ID: 12373428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
    Addolorato G; Caputo F; Capristo E; Domenicali M; Bernardi M; Janiri L; Agabio R; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Alcohol; 2002; 37(5):504-8. PubMed ID: 12217947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of the dopamine D2/D3 antagonist tiapride in maintaining abstinence: a randomized, double-blind, placebo-controlled trial in 299 alcohol-dependent patients.
    Bender S; Scherbaum N; Soyka M; Rüther E; Mann K; Gastpar M
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):653-60. PubMed ID: 17076934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Dopamine Signaling in Drug Addiction.
    Chen W; Nong Z; Li Y; Huang J; Chen C; Huang L
    Curr Top Med Chem; 2017; 17(21):2440-2455. PubMed ID: 28474551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical approaches of binge drinking.
    Rolland B; Karila L; Guardia D; Cottencin O
    Curr Pharm Des; 2011; 17(14):1333-42. PubMed ID: 21524262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T; Nagao N; Nakahara T
    Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
    J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.